Author

Seema Khan

Institution: Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Observed institutions: Northwestern University, University of Colorado Cancer Center, Robert H. Lurie Comprehensive Cancer Center of Northwestern University

OpenAlex ID: A5114090197

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology

2021 · Mary B. Daly, Tuya Pal, et al. · Journal of the National Comprehensive Cancer Network · 1,117

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017

2016 · Mary B. Daly, Robert Pilarski, et al. · Journal of the National Comprehensive Cancer Network · 650

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020

2020 · Mary B. Daly, Robert Pilarski, et al. · Journal of the National Comprehensive Cancer Network · 507

NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024

2023 · Mary B. Daly, Tuya Pal, et al. · Journal of the National Comprehensive Cancer Network · 320

Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015

2016 · Mary B. Daly, Robert Pilarski, et al. · Journal of the National Comprehensive Cancer Network · 292

Reevaluating Cathepsin D as a biomarker for breast cancer: Serum activity levels versus histopathology

2010 · Daniel E Abbott, Naira V Margaryan, et al. · Cancer Biology & Therapy · 44

Works count: 6

Citation count: 2,930

H-index: 6

I10-index: 6